Post-vasectomy semen analysis with a borderline count
A 42-year-old man submits a post-vasectomy semen sample 14 weeks after the procedure. He reports abstinence of 3 days. The laboratory performs a standard semen analysis on a 5 µL wet preparation and a 10 µL Makler chamber count. The wet prep shows 2 motile sperm per high-power field at 400x; the chamber count gives a concentration of 40,000 sperm/mL, of which 6 are motile. Total volume is 2.8 mL. The patient calls the clinic asking whether he can stop using contraception. The referring urologist's protocol states that 'success' requires two consecutive azoospermic samples. The laboratory's SOP defines the lower limit of detection for the chamber method as 10,000 sperm/mL.
1. Interpret the result against the urologist's stated criterion and the laboratory's detection limit. Can this sample be reported as azoospermic, and what should the report say?
Read the worked answer
No - the sample cannot be reported as azoospermic. The chamber count of 40,000 sperm/mL is above the laboratory's stated lower limit of detection (10,000/mL), and motile sperm were seen both on wet prep and in the chamber. Reporting 'no sperm seen' would conflate 'not observed' with 'absent.' The report should state the actual concentration (approximately 40,000/mL), the number of motile sperm observed, the method and volume examined, and the lower limit of detection of the method used. It should explicitly note that rare motile sperm persist and that the sample does not meet the urologist's azoospermia criterion. Because the urologist's protocol requires two consecutive azoospermic samples, this result fails that criterion regardless of the low count.
2. The patient asks whether the residual sperm could still cause a pregnancy. How should the laboratory frame the residual-sperm risk, and what follow-up is appropriate?
Read the worked answer
The laboratory should not tell the patient he is sterile or that he is safe; it should report findings and defer the clinical decision to the urologist. Residual motile sperm after vasectomy are not equivalent to zero risk - the relevant question is whether motile sperm persist on repeat testing, since motility is the feature most associated with fertility potential. A single sample at 14 weeks with 6 motile sperm warrants a repeat sample per the referring protocol (commonly at least 2–4 weeks later, with the same abstinence requirement). The laboratory should recommend repeat testing rather than declaring success or failure, and should document that the patient was advised to continue contraception pending the urologist's review. The report should be flagged for the ordering clinician because the result conflicts with the protocol's 'success' definition.